Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort-Reference-Cited by-同舟云学术

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

Published:2017-06 Issue:6 Volume:66 Page:1138-1148
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Calleja Jose Luis,Crespo Javier,Rincón Diego,Ruiz-Antorán Belén,Fernandez Inmaculada,Perelló Christie,Gea Francisco,Lens Sabela,García-Samaniego Javier,Sacristán Begoña,García-Eliz María,Llerena Susana,Pascasio Juan Manuel,Turnes Juan,Torras Xavier,Morillas Rosa Maria,Llaneras Jordi,Serra Miguel A.,Diago Moises,Rodriguez Conrado Fernández,Ampuero Javier,Jorquera Francisco,Simon Miguel A.,Arenas Juan,Navascues Carmen Alvarez,Bañares Rafael,Muñoz Raquel,Albillos Agustin,Mariño Zoe

Publisher

Elsevier BV

Subject

Hepatology

Reference33 articles.

1. World Health Organization. Hepatitis C Fact sheet N°164. Updated July 2015. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed April 2016.

2. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C;Backus;Clin Gastroenterol Hepatol,2011

3. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;van der Meer;JAMA,2012

4. EASL Recommendations on Treatment of Hepatitis C 2015;J Hepatol,2015

5. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study;Clinical Infectious Diseases;2024-03-21

3. Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study;World Journal of Hepatology;2024-01-27

4. Novel Nomogram for Predicting Hepatocellular Carcinoma in Hepatitis C virus-associated Cirrhosis Patients after eliminating virus with Direct-acting Antivirals;2024-01-19

5. Long-Term Survival and Cancer Risk in the Hepatitis C Virus-Infected Patients After Antiviral Treatment: A Nationwide Cohort Study;Journal of Cancer;2024